Loxapine succinate in the treatment of newly admitted schizophrenic patients
Chouinard, G.; Annable, L.; DeMontigny, C.; Kropsky, M.L.
Current Therapeutic Research 21(1): 73-79
1977
ISSN/ISBN: 0011-393X PMID: 12921 Document Number: 119045
Document emailed within 1 workday
Related Documents
Nair, N.P.; Decker, B.L.; Schwartz, G. 1976: Loxapine succinate in the treatment of chronic schizophrenia Current Therapeutic Research 20(6): 802-809Clark, M.L.; Costiloe, J.P.; Wood, F.; Paredes, A.; Fulkerson, F.G. 1977: Butaclamol in newly admitted chronic schizophrenic patients: a modified fixed-dose dose-range design Diseases of the Nervous System 38(11): 943-947
Varga, E.; Simpson, G.M. 1971: Loxapine succinate in the treatment of uncontrollable destructive behavior Current Therapeutic Research 13(12): 737-742
Bishop, M.P.; Gallant, D.M. 1970: Loxapine: a controlled evaluation in chronic schizophrenic patients Current Therapeutic Research 12(9): 594-597
Gallant, D.M.; Bishop, G.; Steel, C.A.; Bishop, M.P. 1973: Loxapine: a six-month evaluation in severely ill schizophrenic patients Current Therapeutic Research 15(4): 205-209
Frei, A.; Stalder, G.A. 1984: Quality control of liver diagnosis in newly admitted patients Schweizerische Medizinische Wochenschrift 114(26): 953-955
Felger, H.L. 1971: Chlorprothixene-enforced sleep for newly admitted patients with acute mental decompensation Diseases of the Nervous System 32(1): 46-51
Harada, Y.; Kitahara, Y.; Ninomiya, H.; Harada, S.; Takamoto, M.; Ishibashi, T. 1994: A study on drug resistance of newly admitted pulmonary tuberculosis patients with special reference to the resistance to SM, INH, EB and RFP Kekkaku: 69(12): 751-757
Bralet, M.C.; Yon, V.; Loas, G.; Noisette, C. 2000: Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients L'Encephale 26(6): 32-41
Wen, H-Sing.; Wu, H-Lan.; Lee, H-Ju. 2014: Applying a creative art activity in care: report on an experience with a newly admitted resident Hu li za zhi journal of nursing 61(5): 104-110
Jitapunkul, S.; Hanvivadhanakul, P. 1998: Outcomes and predicting factors of mortality among newly admitted female medical inpatients Journal of the Medical Association of Thailand 81(7): 491-496
Sidorenko, G.I.; Komissarova, S.M.; Zolotukhina, S.F.; Petrovskaia, M.E. 2011: He use ethylmethylhydroxypyridine succinate in the treatment of patients with heart failure Kardiologiia 51(6): 44-48
Caroli, F.; Baldacci-Epinette, C.; Ribeyre, P. 1993: Antidepressant treatment of schizophrenic patients L'Encephale 19(Special Issue 2): 393-396
Axelrod, S.; Palgi, E. 1990: Developing an alliance with schizophrenic patients in day hospital treatment Bulletin of the Menninger Clinic 54(3): 340-352
Dzheia, P.P.; Toleĭkis, A.I.; Prashkiavichius, A.K. 1980: Effect of experimental myocardial infarct on the succinate oxidation rate and succinate dehydrogenase activity in the heart mitochondria Voprosy Meditsinskoi Khimii 26(5): 591-594
Munn, N.A. 1993: Resolution of polydipsia and hyponatremia in schizophrenic patients after clozapine treatment Journal of Clinical Psychiatry 54(11): 439
Ivezić, S.; Ljubimir, V.; Urlić, I. 2001: Therapist-patient relationship in treatment of chronic schizophrenic patients Medicinski Arhiv 55(1 Suppl 1: 39-46
Ney, M. 1984: Responsibility of the physician with regard to the third party in the treatment of schizophrenic patients Schweizer Archiv für Neurologie Neurochirurgie und Psychiatrie 135(1): 115-121
Meder, J.; Tyszkowska, M.; Jarema, M.; Araszkiewicz, A.; Szafrański, T. 2008: Antipsychotics in clinical practice. the refractory schizophrenic patients treatment Psychiatria Polska 42(6): 859-873
Quintaliani, G.; Gambirasio, C.; Strippoli, G. 2010: Are there differences in the treatment of kidney patients if they are admitted to general medicine vs nephrology units? Yes, and they are significant Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 27(1): 10-19